Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

G

GANX

Gain Therapeutics Inc

1.17

Nov 03 • 11:56 AM ET +0.04 (3.98%)

Healthcare Biotechnology USA Micro NASD

Peers: DNLI ATHE VYGR ANVS PASG CGTX PMN ACET SUPN AMRX

| Held by: VXF IWC BUSM

Scroll to Statements

Index	-
Market Cap	51.28M
Enterprise Value	38.81M
Income	-20.11M
Sales	0.00M
Book/sh	0.26
Cash/sh	0.30
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	21
IPO	Mar 18, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	4.51
P/C	3.92
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	4.36
Current Ratio	4.36
Debt/Eq	0.05
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	-0.51
EPS next Y	-0.65
EPS next Q	-0.12
EPS this Y	18.55%
EPS next Y	-31.04%
EPS next 5Y	-3.43%
EPS past 3/5Y	25.52% -15.21%
Sales past 3/5Y	- -
EPS Y/Y TTM	23.02%
Sales Y/Y TTM	-
EPS Q/Q	43.08%
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	20.29% -

Insider Own	2.93%
Insider Trans	0.00%
Inst Own	20.27%
Inst Trans	1.03%
ROA	-159.22%
ROE	-268.30%
ROIC	-172.31%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-10.08%
SMA50	-26.00%
SMA200	-36.59%
Trades

Shs Outstand	43.34M
Shs Float	42.36M
Short Float	7.53%
Short Ratio	6.36
Short Interest	3.19M
52W High	4.34 -72.93%
52W Low	1.11 5.86%
Volatility	6.25% 7.63%
ATR (14)	0.10
RSI (14)	32.75
Beta	0.30
Rel Volume	0.46
Avg Volume	501.43K
Volume	94,483

Perf Week	0.43%
Perf Month	-30.47%
Perf Quarter	-34.72%
Perf Half Y	-37.17%
Perf YTD	-63.51%
Perf Year	-36.14%
Perf 3Y	-59.06%
Perf 5Y	-84.84%
Perf 10Y	-
Recom	1.00
Target Price	7.20
Prev Close	1.13
Price	1.17
Change %	3.98%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)